1 |
20–24% |
Asymptomatic to minimally symptomatic |
ground glass opacities, less than 25% of lung involvement |
2 |
18–22% |
symptomatic requiring treatment, limitation of ADLs, but no oxygen requirement |
extensive ground glass opacities extending beyond therapy field with signs of no to minimal focal consolidation, involvement of 25 to 50% of lung |
3 |
8–16% |
symptoms with oxygen requirement |
clear evidence of focal consolidation with or without evidence of fibrosis, more than 50% involvement |
4 |
2–4% |
severe symptoms with persistent oxygen requirement or assisted ventilation |
dense consolidations, atelectasis, traction bronchiectasis with significant pulmonary volume loss |